期刊文献+

补肾通脉汤对兔动脉粥样硬化斑块中MMP-2及TIMP-2表达的早期干预作用 被引量:8

Early Intervention Effects of Bushentongmai Decoction on the Expression of MMP-2 and TIMP-2 in the AS Plaque in Rabbits
下载PDF
导出
摘要 目的:使用补肾通脉汤对兔动脉粥样硬化(atherosclerosis,AS)造模过程进行干预,通过对AS斑块内基质金属蛋白酶-2(matrix metalloproteinase-2,MMP-2)和其基质金属蛋白酶抑制物-2(tissue inhibitor of metalloproteinase-2,TIMP-2)表达的进行检测,探讨补肾通脉汤阻碍AS进展、稳定AS斑块的机制。方法:选取健康新西兰雄性大耳白兔40只,随机分成4组,空白对照组(CG),模型组(MG),补肾通脉组(BSG),阿托伐他汀组(ACG),每组10只,高脂饲料喂养及牛血清白蛋白耳缘静脉注射制作动脉粥样硬化模型,免疫组化法检测斑块内MMP-2和TIMP-2在斑块内的表达的阳性细胞面积。结果:与CG组比较,MG组、BSG组、ACG组MMP-2和TIMP-2表达均有显著升高(P<0.001);与MG组比较,BSG组、ACG组MMP-2和TIMP-2表达均有显著降低(P<0.001,P<0.01),BSG组与ACG组MMP-2和TIMP-2表达无明显区别(P>0.05)。结论:补肾通脉汤可以通过调节MMP-2和TIMP-2在兔AS模型斑块内的表达,有效阻碍AS进展、稳定AS斑块。 Objective:To investigate the mechanisms that affects AS progress and plaque vulnerability through detecting the expression of MMP-2(matrix metalloproteinase-2,MMP-2)and TIMP-2(tissue inhibitor of metalloproteinase-2,TIMP-2)in AS plaques by intervening with Bushentongmai decoction in the model of AS rabbits.Methods :40 male rabbits of New Zealand were divided into two groups at random,CG(control group,CG),MG(model group,MG),BSG(group of bushentongmai decoction,BSG),ACG(group of atorvastatin calcium,ACG),and there are 10 rabbits in every groups.To make AS model by high lipid diet and injecting the vein of ear fringe with BSA(bovine serum albumin,BSA).Analyze the expression of MMP-2 and TIMP-2 in AS plaques by HIS(immunol histochemistry staining,HIS).Result :The expression of MMP-2 and TIMP-2 increased significantly of the other three groups compared with CG(P0.001).The expression of MMP-2 and TIMP-2 decreased significantly in BSG,ACG compared with MG(P0.001,P0.01).There is no difference of the expression of MMP-2 and TIMP-2 between BSIG and ACIG(P0.05).Conclusion :Bushentongmai decoction can regulate the expression of MMP-2 and TIMP-2 in the AS plaques,obstruct the process and stable the AS plaque.
作者 程红 罗陆一
出处 《辽宁中医药大学学报》 CAS 2010年第6期59-60,共2页 Journal of Liaoning University of Traditional Chinese Medicine
基金 广东省中医药管理局资助项目(2009042)
关键词 补肾通脉汤 动脉粥样硬化 基质金属蛋白酶-2 基质金属蛋白酶抑制物-2 bushentongmai decoction atherosclerosis matrix metalloproteinase-2 tissue inhibitor of metalloproteinase-2
  • 相关文献

参考文献6

  • 1Pang IH, Hellberg PE, Fleenor DL, et al. Expression of matrix meta loproteinase and their inhibitors in human trabeeular mesh work ce [ J ].Invest Ophthalmol Vis Sci,2003,44 ( 8 ): 3485.
  • 2任冰稳.动脉粥样硬化与基质金属蛋白酶[J].中国循环杂志,2002,17(1):73-74. 被引量:33
  • 3LI Z, LI L, ZIELKE H R, et al. Increased expression of 72-kd IV type collagenase ( MMP-2 ) in human aortic atheroselerotie lesions[ J ]. Am J Pathol, 1996,148 ( 1 ): 121-128.
  • 4AIMES R T, QUIGLEY J P. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4-and 1/4-length fragments [ J ]. J Biol Chem, 1995,270 ( 11 ): 5872-5876.
  • 5Pang IH, Hellberg PE, Fleenor DL, et al. Expression of matrix meta loproteinase and their inhibitors in human trabecular mesh work ce [ J ]. Invest Ophthalmol Vis Sci, 2003,44 ( 8 ): 3485.
  • 6Hoashi T, Kadono T, Kikuchi K, et al. Differential growth regulation in human melanoma cell lines by TIMP-1 and TIMP-2 [ J ]. Biochem Biophys Res Commun,2001,288 : 371-379.

二级参考文献10

  • 1[1]Nagase H.Activation mechanis ms of matrix metalloproteinases.Biol Che m,1997,378:151-160.
  • 2[2]Brew K,Dinakarpandian D,Nagase H.Tissu e inhibitors of metalloproteinases:evolu tion,structure and function.Biochim Biop hys Acta,2000,1477:267-283.
  • 3[3]Rajavashisth TB,Xu XP,Jovinge S.Membra ne type 1 matrix metalloproteinase expre ssion in human atherosclerotic plaques:e vidence for activation by proinflammator y mediators.Circulation,1999,99:3103-310 9.
  • 4[4]Fitzgerald M,Hayward IP,Thomas AC,et al.Matrix metalloproteinase c an facilitate the heparanase-induced pro motion of phenotype change in vascular s mooth muscle cells.Atherosclerosis,1999, 145:97-106.
  • 5[5]Pasterkamp G,Schoneveld AH,Hijnen DJ,[ WTBZ〗et al.Atherosclerotic arteria l remodeling and the localization of mac rophages and matrix metalloproteases 1,2 and 9 in the human coronary artery.Athe rosclerosis,2000,150:245-253.
  • 6[6]Lee RT,Schoen FJ,Loree HM,et al[ WTBZ〗.Circumferential stress and matrix metalloproteinase 1 in human coronary at herosclerosis.Implications for plaque ru pture.Arterioscler Thromb Vasc Biol,1996 ,16:1070-1073.
  • 7[7]Sukhova GK,Schonbeck U,Rabkin E,et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in v ulnerable human atheromatous plaques.Cir culation,1999,99:2503-2509.
  • 8[8]Lijinen HR,Soloway P,Collen D.Tissure inhibitor of matrix metalloproteinase-1 impairs arterial neointima formation aft er vascular injure in mice.Cir Res,1999, 85:1186-1191.
  • 9[9]Fukumoto Y,Libby P,Rabkin E.Statins al ter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic ra bbits.Circulation,2001,103:993-999.
  • 10[10]Bocan TM,Krause BR,Rosebury WS,e t al.The ACAT inhibitor avasimibe reduce s macrophages and matrix metalloproteina se expression in atherosclerotic lesions of hypercholesterolemic rabbits.Arterio scler Thromb Vasc Biol,2000,20:70-79.

共引文献32

同被引文献154

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部